| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.38 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |